Skip to main content

Table 1 Primer and PCRs used in this study

From: Molecular characterisation of human hepatitis E virus from Italy: comparative analysis of five reverse transcription-PCR assays

Method

Target region

Primer ID

Sequence (5′–3′)

Product length (bp)

Primer position (5′–3′)*

Method A

ORF1

1679

CCAYCAGTTYATHAAGGCTCC

348

36-56

 

1680

TACCAVCGCTGRACRTC

 

383-367

 

1681

CTCCTGGCRTYACWACTGC

172

53-71

 

1682

GGRTGRTTCCAIARVACYTC

 

224-205

Method B

ORF1

1829

ACATTTGAATTATCTGACATTGTGCA

1076

3880-3905

 

1828

ACACACATCTGAGCTACATTCGTGAG

 

4955-4930

 

1830

GACGTGTCCAGGATCACCTTCTTC

559

4147-4170

 

1831

ACTCACTGCAAAGCACTATCGAAT

 

4705-4682

Method C

ORF2

1722

CAAGGHTGGCGYTCKGTTGAGAC

506

5912-5934

 

1723

CCCTTRTCCTGCTGAGCRTTCTC

 

6417-6395

 

1724

GYTCKGTTGAGACCWCBGGBGT

457

5922-5943

 

1725

TTMACWGTCRGCTCGCCATTGGC

 

6378-6356

Method D

ORF2

1837

AATTATGCYCAGTAYCGRGTTG

731

5687-5708

 

1838

CCCTTRTCYTGCTGMGCATTCTC

 

6417-6395

 

1839

GTWATGCTYTGCATWCATGGCT

348

5972-5993

 

1840

AGCCGACGAAATCAATTCTGTC

 

6319-6298

Method E

ORF2/ORF3

1847

GCRGTGGTTTCTGGGGTGAC

164

5259-5278

 

1848

CTGGGMYTGGTCDCGCCAAG

 

5422-5403

 

1849

GYTGATTCTCAGCCCTTCGC

137

5282-5301

 

1850

GMYTGGTCDCGCCAAGHGGA

 

5418-5399

  1. *Primer positions are based on GenBank sequence accession no. M73218.